In surprise decision, US approves muscular dystrophy drug – The Associated Press

WASHINGTON (AP) U.S. health regulators approved a second drug for a debilitating form of muscular dystrophy, a surprise decision after the medication was rejected for safety concerns just four months ago.
The ruling marks the second time the Food and Drug Ad…
Read More

Add Comment